Pituitary tumor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:304055
Who is this for?
Show terms as
9Active trials35Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

A pituitary tumor is an abnormal growth that develops in the pituitary gland, a small pea-sized gland located at the base of the brain, just behind the bridge of the nose. The pituitary gland is often called the "master gland" because it produces hormones that control many other glands and body functions, including growth, metabolism, reproduction, and stress response. Most pituitary tumors are benign (not cancerous) and are called pituitary adenomas. However, even benign tumors can cause significant problems by pressing on nearby structures like the optic nerves (affecting vision) or by producing too much or too little of certain hormones. Pituitary tumors are classified by their size — microadenomas are smaller than 10 millimeters, while macroadenomas are 10 millimeters or larger. They are also classified by whether they produce excess hormones (functioning tumors) or not (non-functioning tumors). Functioning tumors can cause a wide range of symptoms depending on which hormone is overproduced, such as Cushing's disease (too much cortisol), acromegaly (too much growth hormone), or prolactinoma (too much prolactin). Treatment depends on the type, size, and hormone activity of the tumor. Options include medication (especially for prolactinomas), surgery (usually through the nose in a procedure called transsphenoidal surgery), and radiation therapy. Many patients can be effectively managed with these approaches, though long-term monitoring is usually needed. Some pituitary tumors are discovered incidentally on brain imaging done for other reasons and may only require watchful waiting.

Key symptoms:

HeadachesVision problems, especially loss of side (peripheral) visionUnexplained weight gainFatigue and low energyIrregular or absent menstrual periods in womenErectile dysfunction or decreased sex drive in menUnexplained milk production from the breasts (galactorrhea)Enlarged hands, feet, or facial features (acromegaly)Easy bruising and round face (Cushing's features)Mood changes, anxiety, or depressionInfertilityExcessive thirst and frequent urinationGrowth problems in children (too much or too little growth)NauseaFeeling cold or having low blood pressure

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026Safety and Potency of a High Cabergoline Dosage in Microprolactinomas

University of Sao Paulo General Hospital — PHASE3

TrialRECRUITING
Mar 2026Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

West China Hospital — NA

TrialNOT YET RECRUITING
Nov 2025Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors

Peking Union Medical College Hospital — EARLY_PHASE1

TrialENROLLING BY INVITATION
Aug 2025Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

University Medical Center Groningen

TrialNOT YET RECRUITING
Jun 2025The PROMISE Survey

University Hospital, Basel, Switzerland

TrialACTIVE NOT RECRUITING
Oct 2024Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University — NA

TrialNOT YET RECRUITING
Jul 2024ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery

University of California, San Francisco

TrialNOT YET RECRUITING
Jun 2024A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

H. Lundbeck A/S — PHASE2

TrialRECRUITING
Feb 2024A Study of Pasireotide in People With Prolactinoma

Memorial Sloan Kettering Cancer Center — PHASE2

TrialRECRUITING
Jan 2024Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery

The First Affiliated Hospital of Xiamen University — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Pituitary tumor.

9 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

9 recruitingView all trials with filters →
Phase 31 trial
Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
Phase 3
Actively Recruiting
· Sites: Belo Horizonte; Botucatu +14 more · Age: 1899 yrs
Phase 22 trials
A Study of Pasireotide in People With Prolactinoma
Phase 2
Actively Recruiting
PI: Eliza Geer, MD (Memorial Sloan Kettering Cancer Center) · Sites: Basking Ridge, New Jersey; Middletown, New Jersey +5 more · Age: 1899 yrs
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
Phase 2
Actively Recruiting
PI: Email contact via H. Lundbeck A/S (HQ_Medinfo@Lundbeck.com) · Sites: Ann Arbor, Michigan; Angers, Cedex 09 +24 more · Age: 1870 yrs
N/A2 trials
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
N/A
Actively Recruiting
· Sites: Phoenix, Arizona; Cleveland, Ohio · Age: 1985 yrs
Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage
N/A
Actively Recruiting
PI: Abel Huang, MD (National Taiwan University Hospital) · Sites: Taipei · Age: 2099 yrs
Other3 trials
Pituitary Tumor Surveillance: Pathogenic Correlation
Actively Recruiting
PI: Shlomo Melmed, MD (Cedars-Sinai Medical Center, Pituitary Center) · Sites: Los Angeles, California · Age: 1899 yrs
The PROMISE Survey
Active
PI: Cihan Atila (University Hospital, Basel, Switzerland) · Sites: Basel · Age: 1899 yrs
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
Actively Recruiting
· Sites: Guangzhou, Guangdong · Age: 1870 yrs

Specialists

Showing 25 of 35View all specialists →
SM
Shlomo Melmed, MD
LOS ANGELES, CA
Specialist
PI on 7 active trials
AM
Andrew Little, MD
Specialist
PI on 3 active trials1 Pituitary tumor publication
ÜB
Ülkü Çolakoğlu, BSN
Specialist
PI on 1 active trial
SP
Seher Ünver, Assoc. Prof.
Specialist
PI on 1 active trial
PM
Pamela U. Freda, MD
NEW YORK, NY
Specialist
PI on 4 active trials
LM
Lynnette K Nieman, M.D.
BETHESDA, MD
Specialist
PI on 9 active trials
AP
Annamaria Colao, MD, PhD
Specialist
PI on 3 active trials
AM
Andreas Moraitis, MD
SUNNY ISLES BEACH, FL
Specialist
PI on 2 active trials
DM
Deborah P Merke, M.D.
BETHESDA, MD
Specialist
PI on 7 active trials
PM
Prashant Chittiboina, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 7 active trials
AM
Andreas G Moraitis, MD
SUNNY ISLES BEACH, FL
Specialist
PI on 2 active trials1 Pituitary tumor publication
TX
Tao Xie
Specialist
PI on 3 active trials33 Pituitary tumor publications
AM
Abel Huang, MD
Specialist
PI on 1 active trial1 Pituitary tumor publication
CP
Chul-Kee Park, MD PhD
Specialist
PI on 1 active trial
LM
Linton T Evans, MD
HOUSTON, TX
Specialist
PI on 1 active trial1 Pituitary tumor publication
AM
ARNAUD MARTEL
Specialist
PI on 1 active trial2 Pituitary tumor publications
AP
Annamaria AL Colao, Prof.
Specialist
PI on 3 active trials
DM
David M Kleinberg, MD
LAKE CITY, SD
Specialist
PI on 1 active trial
JM
John Suh, MD
Specialist
PI on 1 active trial
EM
Erika CO Naliato, MSc
Specialist
PI on 1 active trial
EU
Eva Jakobsson Ung
FOUNTAIN VALLEY, CA
Specialist
PI on 1 active trial
HW
Hung-Chen Wang
Specialist
PI on 1 active trial
EG
Eliza Geer
HUNTINGTON, WV
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pituitary tumor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pituitary tumorForum →

No community posts yet. Be the first to share your experience with Pituitary tumor.

Start the conversation →

Latest news about Pituitary tumor

Disease timeline:

New recruiting trial: Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery

A new clinical trial is recruiting patients for Pituitary tumor

New recruiting trial: Pituitary Tumor Surveillance: Pathogenic Correlation

A new clinical trial is recruiting patients for Pituitary tumor

New recruiting trial: Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery

A new clinical trial is recruiting patients for Pituitary tumor

New recruiting trial: A Study of Pasireotide in People With Prolactinoma

A new clinical trial is recruiting patients for Pituitary tumor

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type of pituitary tumor do I have, and is it producing excess hormones?,What is the size of my tumor, and is it pressing on any important structures like the optic nerves?,What are my treatment options, and what do you recommend as the first step?,Will I need hormone replacement therapy, and if so, for how long?,Should I be tested for a genetic or familial syndrome?,How often will I need follow-up MRI scans and blood tests?,What emergency symptoms should I watch for, and what should I do if they occur?

Common questions about Pituitary tumor

What is Pituitary tumor?

A pituitary tumor is an abnormal growth that develops in the pituitary gland, a small pea-sized gland located at the base of the brain, just behind the bridge of the nose. The pituitary gland is often called the "master gland" because it produces hormones that control many other glands and body functions, including growth, metabolism, reproduction, and stress response. Most pituitary tumors are benign (not cancerous) and are called pituitary adenomas. However, even benign tumors can cause significant problems by pressing on nearby structures like the optic nerves (affecting vision) or by produ

How is Pituitary tumor inherited?

Pituitary tumor follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pituitary tumor typically begin?

Typical onset of Pituitary tumor is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Pituitary tumor?

Yes — 9 recruiting clinical trials are currently listed for Pituitary tumor on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Pituitary tumor?

25 specialists and care centers treating Pituitary tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.